Global Airway Stent Market Size By Type (Tracheal Stents, Laryngeal Stents), By Application (Hospitals, Ambulatory Surgery Centres), By Region, And Segment Forecasts, 2023 to 2032

The Global Airway Stent Market was valued at USD 492 million in 2023 and is expected to reach USD 814 million by 2031, expanding at a CAGR of 6.6% during the forecast period from 2023 to 2031. The increasing incidence of chronic respiratory diseases, growing preference for minimally invasive procedures, and advancements in stent design and materials are fueling market growth. Airway stents are widely used to treat tracheobronchial obstructions, both malignant and benign, offering effective palliation and quality of life improvements for patients. The rising geriatric population and heightened awareness of respiratory health are also contributing to market expansion.

Drivers:

1. Rising Prevalence of Respiratory Diseases:

Conditions such as COPD, asthma, and lung cancer are increasingly common globally. These ailments often lead to airway obstructions requiring stent placement, thus driving demand.

2. Technological Advancements in Stent Design:

Newer materials such as hybrid stents and drug-eluting variants are providing enhanced patient outcomes, reducing complications and boosting the adoption rate.

3. Increasing Demand for Minimally Invasive Procedures:

With a growing focus on patient comfort and reduced recovery time, clinicians are increasingly turning to minimally invasive options like airway stenting over traditional surgical interventions.

Restraints:

1. High Cost of Procedures and Devices:

The substantial costs associated with airway stent procedures, particularly in private healthcare systems, can limit access in cost-sensitive regions.

2. Risk of Complications:

Despite advancements, complications such as stent migration, granulation tissue formation, and infection remain, deterring wider adoption among certain patient groups.

Opportunity:

1. Expansion in Emerging Markets:

Rising healthcare investments and awareness in emerging economies like India, China, and Brazil provide lucrative growth opportunities for market players.

2. Development of Biodegradable and Drug-Eluting Stents:

Ongoing R&D efforts to develop stents that offer therapeutic benefits or degrade naturally post-treatment represent a promising area for innovation.

Market by System Type Insights:

By system type, the Self-expanding Stents segment dominated the market in 2023, owing to their ease of deployment, adaptability to airway shape, and reduced risk of trauma during insertion. These stents are preferred in malignant obstructions where immediate relief is crucial. Meanwhile, Balloon-expandable Stents are anticipated to gain traction in select clinical applications due to their precise placement advantages, particularly in pediatric cases and complex airway anatomies.

Market by End-use Insights:

Hospitals accounted for the largest market share in 2023, driven by the increasing number of interventional pulmonology procedures and better availability of advanced imaging and surgical tools. Ambulatory Surgical Centers (ASCs) are expected to witness faster growth due to their cost-effectiveness, reduced patient stay durations, and rising preference for outpatient procedures.

Market by Regional Insights:

North America led the global airway stent market in 2023, thanks to its advanced healthcare infrastructure, high diagnosis rates, and the presence of major market players. Asia-Pacific is projected to grow at the highest CAGR during the forecast period, supported by rapid urbanization, increasing healthcare awareness, and a growing patient pool affected by respiratory conditions. Europe also holds a significant share, aided by favorable reimbursement policies and early adoption of new medical technologies.

Competitive Scenario:

Key players in the Global Airway Stent Market include Boston Scientific Corporation, Merit Medical Systems Inc., Cook Medical, Novatech SA, Micro-Tech (Nanjing) Co., Ltd., Taewoong Medical Co. Ltd., and Boston Medical Products Inc. These companies are focused on product innovation, expanding their geographical footprint, and forming strategic partnerships with healthcare providers. For example:

In 2024, Boston Scientific launched a new silicone-covered self-expanding metal stent with improved anti-migration features.

Taewoong Medical expanded its distribution agreement with European partners to strengthen its presence in the EU market.

Micro-Tech introduced a next-generation drug-eluting airway stent in early clinical trials aimed at reducing post-placement complications.

Scope of Work – Global Airway Stent Market

Report Metric Details

Market Size (2023) USD 492 million

Projected Market Size (2031) USD 814 million

CAGR (2023–2031) 6.6%

Market Segments By System Type (Self-expanding, Balloon-expandable), By End-use (Hospitals, ASCs), By Region

Growth Drivers Rising respiratory disease prevalence, technological advancements, and growing demand for minimally invasive procedures

Opportunities Emerging market expansion, biodegradable and drug-eluting stents

Key Market Developments:

March 2024: Cook Medical received CE approval for a new fully covered metal stent designed for